Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003004
Filing Date
2017-04-28
Accepted
2017-04-27 18:19:04
Documents
9
Period of Report
2017-06-13
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231878zdef14a.htm DEF 14A 667770
2 G399823.JPG g399823.jpg GRAPHIC 30282
3 G918867.JPG g918867.jpg GRAPHIC 6400
4 G20428.JPG g20428.jpg GRAPHIC 6281
5 G512034.JPG g512034.jpg GRAPHIC 28942
6 G987977.JPG g987977.jpg GRAPHIC 29794
7 G21422BGI001.GIF g21422bgi001.gif GRAPHIC 101504
8 G21422BII001.GIF g21422bii001.gif GRAPHIC 67731
9 G21422BKI001.GIF g21422bki001.gif GRAPHIC 97469
  Complete submission text file 0001047469-17-003004.txt   1177257
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33497 | Film No.: 17790829
SIC: 2834 Pharmaceutical Preparations